BPI 2026 · Biotech

Gokyo Biosciences at BPI 2026

Gokyo Biosciences brings 2 presentations to BPI 2026 in Boston. Its program centres on making biologics affordable and on scaling gene therapy manufacturing. One session covers ways to reduce manufacturing complexity and cost of goods so that affordability is engineered into a biologic.

OrganizationBPI 2026 Attendance
1 President and CEO
gokyobio.com
Biotech
New Jersey biologics developer building a pipeline of affordable biologic medicines using in-house CMC expertise and external manufacturing partners.
Talk
Wed Sep 23
9:00am–9:30am
Engineering Affordability into Biologics: Strategies to Reduce Manufacturing Complexity and COGS
CMC Strategy & Manufacturing Performance
Keynote
Thu Sep 24
9:00am–10:00am
Keynote Panel Discussion: Strategies for Scaling Up, Accelerating and Commercializing Gene Therapy Manufacturing
Gene Therapy Manufacturing & Analytics · with University College Cork, Sangamo Therapeutics, REGENXBIO +2 more

Explore the full BPI 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Boston. Leave your work email and we’ll be in touch.

Privacy

Download the full BPI 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Gokyo Biosciences

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by Informa Connect or the BioProcess International Conference & Exhibition. Submit a correction